Paper37605
The beta-adrenergic blocking agents and the treatment of glaucoma.
Zimmerman TJ and 1 other. Surv Ophthalmol, 1979. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. The beta-adrenergic blocking agents and the treatment of glaucoma. Papers, record 37605. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37605
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Glaucoma | Major topic |
| Propanolamines | Major topic |
| Timolol | Major topic |
| Animals | |
| Aqueous Humor | |
| Autonomic Nervous System | |
| Dogs | |
| Dose-Response Relationship, Drug | |
| Evaluation Studies as Topic | |
| Eye | |
| Humans | |
| Intraocular Pressure | |
| Rabbits | |
| Time Factors | |
| Tissue Distribution |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31861609 | Synthesis and Application of 1,2-Aminoalcohols with Neoisopulegol-Based Octahydrobenzofuran Core. | Molecules | 2019 | https://conductscience.org/library/papers/31861609 | PubMed |
| 31057923 | Towards smart self-clearing glaucoma drainage device. | Microsyst Nanoeng | 2018 | https://conductscience.org/library/papers/31057923 | PubMed |
| 29606703 | The Importance of Medicinal Chemistry Knowledge in the Clinical Pharmacist's Education. | Am J Pharm Educ | 2018 | https://conductscience.org/library/papers/29606703 | PubMed |
| 29343839 | Musical auditory stimulus acutely influences heart rate dynamic responses to medication in subjects with well-controlled hypertension. | Sci Rep | 2018 | https://conductscience.org/library/papers/29343839 | PubMed |
| 27916026 | Role of cyclic AMP in the eye with glaucoma. | BMB Rep | 2017 | https://conductscience.org/library/papers/27916026 | PubMed |
| 19266054 | Pharmacogenetics of ophthalmic topical beta-blockers. | Per Med | 2008 | https://conductscience.org/library/papers/19266054 | PubMed |
| 17542770 | Pharmacogenetics of beta-blockers. | Pharmacotherapy | 2007 | https://conductscience.org/library/papers/17542770 | PubMed |
| 7042481 | A dose-response study of oral atenolol administered once daily in patients with raised intra-ocular pressure. | Graefes Arch Clin Exp Ophthalmol | 1982 | https://conductscience.org/library/papers/7042481 | PubMed |
| 6351901 | Comparison of ocular hypotensive effects of 3 dosages of oral atenolol. | Br J Ophthalmol | 1983 | https://conductscience.org/library/papers/6351901 | PubMed |
| 6338906 | Effect of pindolol on intraocular pressure in glaucoma: pilot study and a randomised comparison with timolol. | Br J Ophthalmol | 1983 | https://conductscience.org/library/papers/6338906 | PubMed |
| 6293532 | Beta adrenergic receptors in pigmented ciliary processes. | Br J Ophthalmol | 1982 | https://conductscience.org/library/papers/6293532 | PubMed |
| 6261257 | Adrenergic regulation of intraocular pressure: identification of beta 2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6261257 | PubMed |
| 6150744 | ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6150744 | PubMed |
| 6116512 | Effects of a potent and specific beta 2-adrenoceptor antagonist on intraocular pressure. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/6116512 | PubMed |
| 6092239 | R-enantiomer of timolol: a potential selective ocular antihypertensive agent. | Graefes Arch Clin Exp Ophthalmol | 1984 | https://conductscience.org/library/papers/6092239 | PubMed |
| 2579877 | Effects of S-596 and carteolol, new beta-adrenergic blockers, and flurbiprofen on the human eye: a fluorophotometric study. | Graefes Arch Clin Exp Ophthalmol | 1985 | https://conductscience.org/library/papers/2579877 | PubMed |
| 1351412 | Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects. | Drugs Aging | 1992 | https://conductscience.org/library/papers/1351412 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IGKV5-2 | 28907 | PubTator's text mining | https://conductscience.org/library/genes/28907 | NCBI Gene |
| MS4A1 | 931 | PubTator's text mining | https://conductscience.org/library/genes/931 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37605
GET https://conductscience.org/api/papers/v1/37605/authors